Navigation Links
Kenneth Kensey, Inventor of the Angio-Seal(R), Dies at 58
Date:7/9/2009

PHILADELPHIA, June 9 /PRNewswire/ -- Kenneth R. Kensey, prolific inventor, successful entrepreneur and progressive physician, died July 3rd at Reading Hospital in West Reading, Pennsylvania of brain hemorrhage. Dr. Kensey, co-founder of Kensey-Nash Corporation, is the inventor or co-inventor in more than 130 patent filings with more than 50 patents issued. He was 58.

The inventor of the Angio-Seal(R) artery plug and the Rheolog(R) blood viscometer, Kensey made significant contributions to minimally invasive surgery and was recognized as a pioneer for his theories on the cause of heart disease.

Kensey was born in Everett, PA, the son of Edward I. Kensey and Fay L. Ritchey Kensey. He graduated from Ohio Wesleyan University and received his medical degree from Ohio State University. After a cardiology fellowship at Michael Reese Hospital in Chicago, Kensey entered private practice where he began to see the need for innovations in the device technologies used in medicine.

With John E. Nash, Kensey founded Kensey-Nash Corporation in 1984, where he was responsible for creating numerous new medical technologies including the Angio-Seal(R), the leading femoral artery puncture closure device marketed by St. Jude Medical, as well as the Kensey Catheter for Dynamic Angioplasty. Dr. Kensey's devices are in use worldwide. His inventions have contributed to saving millions of lives.

During his tenure as CEO of Kensey-Nash, Kensey was instrumental in facilitating joint ventures with Baxter Health Care, Johnson & Johnson, American Home Products, Cordis, and Tyco Medical.

In 1998, Kensey left Kensey-Nash to form Rheologics, Inc. (formerly, Visco Technologies, Inc.), where he developed the first in-vivo blood viscometer for use at the bedside in the diagnosis and treatment of atherosclerosis. He served as CEO of Rheologics until 2005 and Chairman until 2009.

Kensey was the author of 17 journal articles, including contributions to the Journal of Invasive Cardiology and the Review of Scientific Instruments. He co-wrote The Origin of Atherosclerosis: What Really Initiates the Inflammatory Process, and The Blood Thinner Cure: A Revolutionary Seven-Step Lifestyle Plan for Stopping Heart Disease and Stroke. He was an invited lecturer at Harvard Medical School, the American College of Cardiology, Stanford University, the Mayo Clinic, UCLA, and the Arizona Heart Institute.

ProMetrics, Inc., based in King of Prussia, PA and formed in 1994, is an active investor in emerging medical technology and service companies. In 2007 ProMetrics invested in SLIM Tech, LLC, a development stage medical device company based on Dr. Kensey's patents for an implantable lymphatic device to remove lipids. Dr. Kensey was directing the research effort for SLIM Tech, LLC.


'/>"/>
SOURCE Prometrics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
2. Kenneth A. Sylvia Named as New Publisher of Current Psychiatry
3. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
4. Dr. Kenneth L. Byrd Joins SteriFx Inc.
5. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
6. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
7. Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas
8. Collegiate Inventors Competition(R) Announces Winners for 2007
9. Collegiate Inventors Competition announces winners for 2007
10. SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth
11. National Inventors Hall of Fame announces 2008 inductees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Z-Medica, LLC, a leading developer and marketer ... will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 schools ... by the American College of Surgeons, U.S. Department of Defense, Department of Homeland ...
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... Conn. (PRWEB) , ... March 28, 2017 , ... ... based in Wethersfield, Conn., has relocated its corporate headquarters to a new, more ... clients. , In October 2016, Qualidigm purchased a distressed office building in ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process ... in power plant water and steam. , Chlorides and sulfates cause pitting and ... to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin ... one of few medical professionals in the country to sit on the 2017 National ... Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a small ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... DIEGO and VANCOUVER, British Columbia, March 27, 2017 ... ) (the "Company" or "Sophiris"), a clinical late-stage ... of patients with urological diseases, today reported fourth ... key corporate highlights. Key Corporate ... Clinical Development for Localized Prostate Cancer. During 2016, ...
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... -- The staggering cost of cancer treatment means only ... the latest treatment options against cancer. Even among the ... inadequate or no health insurance and are oftentimes saddled ... modern cancer treatment is almost non-existent for cancer patients ... mission statements of pharmaceutical and biotech companies often quote ...
Breaking Medicine Technology: